The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches

BMC Infectious Diseases

Table 5 Direct medical costs of genital herpes among claims database enrollees and extrapolated US estimates

Type of patient	Mean cost ($)	SD ($)	Median cost ($)	Mean total US costs
				(in Mio $)
Incident GH	235	418	86	30.8
Prevalent GH	166	393	43	89.8
Active GH	355	536	191	21.8
Recurrent GH	499	707	359	101.6

ISSN: 1471-2334